Elevated ROS production augments IL-8 and VEGF synthesis in breast cancer cells and enhances MMP secretion, supporting new blood vessel growth and cancer cell migration in the tumor microenvironment and consequently increasing the risk of breast cancer cell intravasation and metastasis (32, 83). Here, VEGFA is linked to cancer.